# Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis

> **NCT06835023** · NA · RECRUITING · sponsor: **Satu Mare County Emergency Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Acute Pancreatitis (AP)
- Acute Pancreatic Fluid Collection
- Fluid Resuscitation

## Interventions

- **DRUG:** Ringer lactate (RLS)
- **DRUG:** Dextran+Ringer Lactat(D+RLS)

## Key facts

- **NCT ID:** NCT06835023
- **Lead sponsor:** Satu Mare County Emergency Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-10
- **Primary completion:** 2025-05-12
- **Final completion:** 2025-05-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06835023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06835023, "Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06835023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*